Selected research
Industry Research
Contraceptive Injectable Industry Research Report 2026
Market perspective
The global Contraceptive Injectable market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Contraceptive Injectable is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Contraceptive Injectable is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Contraceptive Injectable is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Contraceptive Injectable include Janssen Pharmaceuticals, Inc., Pfizer Inc., China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Bayer AG, Veru, Inc., Organon Group Of Companies, Church & Dwight, Agile Therapeutics and Afaxys, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Contraceptive Injectable market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Contraceptive Injectable Market by Company
Janssen Pharmaceuticals, Inc.
Pfizer Inc.
China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
Bayer AG
Veru, Inc.
Organon Group Of Companies
Church & Dwight
Agile Therapeutics
Afaxys, Inc.
Contraceptive Injectable Segment by Type
Long-Acting Contraception
Short-Acting Contraception
Contraceptive Injectable Segment by Application
Male
Female
Contraceptive Injectable Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Injectable market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Injectable and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Injectable.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Contraceptive Injectable manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Contraceptive Injectable by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Contraceptive Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Long-Acting Contraception
- Short-Acting Contraception
Applications
- Male
- Female
Companies covered
- Janssen Pharmaceuticals, Inc.
- Pfizer Inc.
- China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
- Bayer AG
- Veru, Inc.
- Organon Group Of Companies
- Church & Dwight
- Agile Therapeutics
- Afaxys, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Contraceptive Injectable Market Size (2021-2032)
- 2.2.2 Global Contraceptive Injectable Sales (2021-2032)
- 2.2.3 Global Contraceptive Injectable Market Average Price (2021-2032)
- 2.3 Contraceptive Injectable by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Long-Acting Contraception
- 2.3.3 Short-Acting Contraception
- 2.4 Contraceptive Injectable by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Male
- 2.4.3 Female
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Contraceptive Injectable Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Contraceptive Injectable Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Contraceptive Injectable Revenue of Manufacturers (2021-2026)
- 3.4 Global Contraceptive Injectable Average Price by Manufacturers (2021-2026)
- 3.5 Global Contraceptive Injectable Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Contraceptive Injectable, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Contraceptive Injectable, Product Type & Application
- 3.8 Global Manufacturers of Contraceptive Injectable, Established Date
- 3.9 Global Contraceptive Injectable Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Janssen Pharmaceuticals, Inc.
- 4.1.1 Janssen Pharmaceuticals, Inc. Company Information
- 4.1.2 Janssen Pharmaceuticals, Inc. Business Overview
- 4.1.3 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product Portfolio
- 4.1.5 Janssen Pharmaceuticals, Inc. Recent Developments
- 4.2 Pfizer Inc.
- 4.2.1 Pfizer Inc. Company Information
- 4.2.2 Pfizer Inc. Business Overview
- 4.2.3 Pfizer Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Inc. Contraceptive Injectable Product Portfolio
- 4.2.5 Pfizer Inc. Recent Developments
- 4.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
- 4.3.1 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Company Information
- 4.3.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Business Overview
- 4.3.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product Portfolio
- 4.3.5 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Developments
- 4.4 Bayer AG
- 4.4.1 Bayer AG Company Information
- 4.4.2 Bayer AG Business Overview
- 4.4.3 Bayer AG Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer AG Contraceptive Injectable Product Portfolio
- 4.4.5 Bayer AG Recent Developments
- 4.5 Veru, Inc.
- 4.5.1 Veru, Inc. Company Information
- 4.5.2 Veru, Inc. Business Overview
- 4.5.3 Veru, Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Veru, Inc. Contraceptive Injectable Product Portfolio
- 4.5.5 Veru, Inc. Recent Developments
- 4.6 Organon Group Of Companies
- 4.6.1 Organon Group Of Companies Company Information
- 4.6.2 Organon Group Of Companies Business Overview
- 4.6.3 Organon Group Of Companies Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Organon Group Of Companies Contraceptive Injectable Product Portfolio
- 4.6.5 Organon Group Of Companies Recent Developments
- 4.7 Church & Dwight
- 4.7.1 Church & Dwight Company Information
- 4.7.2 Church & Dwight Business Overview
- 4.7.3 Church & Dwight Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Church & Dwight Contraceptive Injectable Product Portfolio
- 4.7.5 Church & Dwight Recent Developments
- 4.8 Agile Therapeutics
- 4.8.1 Agile Therapeutics Company Information
- 4.8.2 Agile Therapeutics Business Overview
- 4.8.3 Agile Therapeutics Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Agile Therapeutics Contraceptive Injectable Product Portfolio
- 4.8.5 Agile Therapeutics Recent Developments
- 4.9 Afaxys, Inc.
- 4.9.1 Afaxys, Inc. Company Information
- 4.9.2 Afaxys, Inc. Business Overview
- 4.9.3 Afaxys, Inc. Contraceptive Injectable Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Afaxys, Inc. Contraceptive Injectable Product Portfolio
- 4.9.5 Afaxys, Inc. Recent Developments
5 Global Contraceptive Injectable Market Scenario by Region
- 5.1 Global Contraceptive Injectable Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Contraceptive Injectable Sales by Region: 2021-2032
- 5.2.1 Global Contraceptive Injectable Sales by Region: 2021-2026
- 5.2.2 Global Contraceptive Injectable Sales by Region: 2027-2032
- 5.3 Global Contraceptive Injectable Revenue by Region: 2021-2032
- 5.3.1 Global Contraceptive Injectable Revenue by Region: 2021-2026
- 5.3.2 Global Contraceptive Injectable Revenue by Region: 2027-2032
- 5.4 North America Contraceptive Injectable Market Facts & Figures by Country
- 5.4.1 North America Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Contraceptive Injectable Sales by Country (2021-2032)
- 5.4.3 North America Contraceptive Injectable Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Contraceptive Injectable Market Facts & Figures by Country
- 5.5.1 Europe Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Contraceptive Injectable Sales by Country (2021-2032)
- 5.5.3 Europe Contraceptive Injectable Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Contraceptive Injectable Market Facts & Figures by Country
- 5.6.1 Asia Pacific Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Contraceptive Injectable Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Contraceptive Injectable Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Contraceptive Injectable Market Facts & Figures by Country
- 5.7.1 South America Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Contraceptive Injectable Sales by Country (2021-2032)
- 5.7.3 South America Contraceptive Injectable Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Contraceptive Injectable Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Contraceptive Injectable Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Contraceptive Injectable Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Contraceptive Injectable Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Contraceptive Injectable Sales by Type (2021-2032)
- 6.1.1 Global Contraceptive Injectable Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Contraceptive Injectable Sales Market Share by Type (2021-2032)
- 6.2 Global Contraceptive Injectable Revenue by Type (2021-2032)
- 6.2.1 Global Contraceptive Injectable Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Contraceptive Injectable Revenue Market Share by Type (2021-2032)
- 6.3 Global Contraceptive Injectable Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Contraceptive Injectable Sales by Application (2021-2032)
- 7.1.1 Global Contraceptive Injectable Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Contraceptive Injectable Sales Market Share by Application (2021-2032)
- 7.2 Global Contraceptive Injectable Revenue by Application (2021-2032)
- 7.2.1 Global Contraceptive Injectable Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Contraceptive Injectable Revenue Market Share by Application (2021-2032)
- 7.3 Global Contraceptive Injectable Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Contraceptive Injectable Value Chain Analysis
- 8.1.1 Contraceptive Injectable Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Contraceptive Injectable Production Mode & Process
- 8.2 Contraceptive Injectable Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Contraceptive Injectable Distributors
- 8.2.3 Contraceptive Injectable Customers
9 Global Contraceptive Injectable Analyzing Market Dynamics
- 9.1 Contraceptive Injectable Industry Trends
- 9.2 Contraceptive Injectable Industry Drivers
- 9.3 Contraceptive Injectable Industry Opportunities and Challenges
- 9.4 Contraceptive Injectable Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst